Nomura Research Institute Ltd.Nomura Research Institute Ltd.Nomura Research Institute Ltd.

Nomura Research Institute Ltd.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.25USD
Revenue estimate
‪1.20 B‬USD
Market capitalization
‪14.94 B‬USD
‪526.21 M‬USD
‪4.87 B‬USD
‪396.83 M‬
Beta (1Y)
0.98

About NOMURA RESEARCH INSTITUTE

CEO
Kaga Yanagisawa
Website
Headquarters
Tokyo
Founded
1965
ISIN
JP3762800005
FIGI
BBG000LCXSH3
Nomura Research Institute Ltd. engages in the provision of research, business consulting, and systems services. It operates through the following segments: Consulting, Financial Information Technology (IT) Solutions, Industrial IT Solutions, and IT Platform Services. The Consulting segment provides management and systems consulting services. The Financial IT Solutions segment offers IT solutions for securities, banking, and insurance sectors. The Industrial IT Solutions segment deals with IT solutions and infrastructure services for distribution, manufacturing, service, and healthcare industries, as well as for government and other public agencies. The IT Platform Services segment handles data center operation management, IT infrastructure, and network construction. It also conducts research for the development of new business operations and new products related to IT solutions. The company was founded on April 1, 1965 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NURAF is 25.80 USD — it has increased by 0.78% in the past 24 hours. Watch Nomura Research Institute Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nomura Research Institute Ltd. stocks are traded under the ticker NURAF.
Nomura Research Institute Ltd. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
NURAF stock is 4.31% volatile and has beta coefficient of 0.98. Track Nomura Research Institute Ltd. stock price on the chart and check out the list of the most volatile stocks — is Nomura Research Institute Ltd. there?
NURAF earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.26 USD resulting in a 9.79% surprise. The estimated earnings for the next quarter are 0.25 USD per share. See more details about Nomura Research Institute Ltd. earnings.
Nomura Research Institute Ltd. revenue for the last quarter amounts to ‪1.33 B‬ USD despite the estimated figure of ‪1.34 B‬ USD. In the next quarter revenue is expected to reach ‪1.24 B‬ USD.
Yes, you can track Nomura Research Institute Ltd. financials in yearly and quarterly reports right on TradingView.
NURAF stock has risen by 6.68% compared to the previous week, the month change is a 8.58% fall, over the last year Nomura Research Institute Ltd. has showed a 2.71% increase.
NURAF net income for the last quarter is ‪122.56 M‬ USD, while the quarter before that showed ‪166.06 M‬ USD of net income which accounts for −26.19% change. Track more Nomura Research Institute Ltd. financial stats to get the full picture.
Today Nomura Research Institute Ltd. has the market capitalization of ‪15.17 B‬, it has increased by 2.08% over the last week.
Nomura Research Institute Ltd. dividend yield was 1.25% in 2023, and payout ratio reached 38.71%. The year before the numbers were 1.47% and 34.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NURAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nomura Research Institute Ltd. stock right from TradingView charts — choose your broker and connect to your account.
NURAF reached its all-time high on Sep 14, 2018 with the price of 48.70 USD, and its all-time low was 21.66 USD and was reached on Nov 8, 2022. View more price dynamics on NURAF chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nomura Research Institute Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nomura Research Institute Ltd. stock shows the sell signal. See more of Nomura Research Institute Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Nomura Research Institute Ltd. future price: according to them, NURAF price has a max estimate of 33.15 USD and a min estimate of 25.03 USD. Watch NURAF chart and read a more detailed Nomura Research Institute Ltd. stock forecast: see what analysts think of Nomura Research Institute Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nomura Research Institute Ltd. EBITDA is ‪1.10 B‬ USD, and current EBITDA margin is 22.65%. See more stats in Nomura Research Institute Ltd. financial statements.